Vincent Medical Holdings Limited (HKG:1612)
Hong Kong · Delayed Price · Currency is HKD | Market Cap | 445.57M -28.7% |
| Revenue (ttm) | 964.90M +10.9% |
| Net Income | 96.30M +10.0% |
| EPS | 0.15 +9.1% |
| Shares Out | 660.10M |
| PE Ratio | 4.55 |
| Forward PE | n/a |
| Dividend | 0.05 (7.70%) |
| Ex-Dividend Date | Sep 8, 2026 |
| Volume | 68,000 |
| Open | 0.6600 |
| Previous Close | 0.6600 |
| Day's Range | 0.6600 - 0.6750 |
| 52-Week Range | 0.6350 - 1.0900 |
| Beta | 0.74 |
| Analysts | n/a |
| Price Target | n/a |
| Est. Earnings | Nov 25, 2026 |
About Vincent Medical Holdings
Vincent Medical Holdings Limited, an investment holding company, research, develops, manufactures, markets, trades in, and sells medical devices. It operates in two segments: Original Equipment Manufacturing (OEM) and Original Brand Manufacturing (OBM). The company develops medical devices focusing on respiratory care, imaging disposables, and orthopedic and rehabilitation products. It offers a range of electronic medical devices, such as high-flow oxygen therapy devices, respiratory humidification systems, and rehabilitation devices, as well a... [Read more]
Financial Performance
In 2025, Vincent Medical Holdings's revenue was 932.78 million, an increase of 16.46% compared to the previous year's 800.96 million. Earnings were 104.38 million, an increase of 50.91%.
Financial StatementsNews
Hong Kong medical device maker to expand China facility amid US, EU barriers
Vincent Medical Holdings, a Hong Kong-based medical device maker, has doubled down on manufacturing in China by investing in automation and digitalisation, instead of moving operations abroad amid ris...